Cellebrite DI (CLBT) Total Non-Current Liabilities: 2020-2024

Historic Total Non-Current Liabilities for Cellebrite DI (CLBT) over the last 5 years, with Dec 2024 value amounting to $59.0 million.

  • Cellebrite DI's Total Non-Current Liabilities rose 20.18% to $69.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.7 million, marking a year-over-year increase of 20.18%. This contributed to the annual value of $59.0 million for FY2024, which is 75.89% down from last year.
  • Per Cellebrite DI's latest filing, its Total Non-Current Liabilities stood at $59.0 million for FY2024, which was down 75.89% from $244.8 million recorded in FY2023.
  • Over the past 5 years, Cellebrite DI's Total Non-Current Liabilities peaked at $244.8 million during FY2023, and registered a low of $40.0 million during FY2020.
  • Its 3-year average for Total Non-Current Liabilities is $141.8 million, with a median of $121.7 million in 2022.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 466.45% in 2021, then tumbled by 75.89% in 2024.
  • Cellebrite DI's Total Non-Current Liabilities (Yearly) stood at $40.0 million in 2020, then skyrocketed by 466.45% to $226.6 million in 2021, then crashed by 46.30% to $121.7 million in 2022, then surged by 101.27% to $244.8 million in 2023, then crashed by 75.89% to $59.0 million in 2024.